Pro Medicus (ASX:PME) - CEO Dr Sam Hupert
CEO Dr Sam Hupert
Source: Pro Medicus
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Pro Medicus (PME)’s wholly owned subsidiary has signed a $40 million contract with Novant Health
  • Visage Imaging penned a seven-year contract, which will see the company’s Visage 7 Enterprise Imaging Platform and Visage 7 Workflow module implemented throughout Novant Health
  • Planning for the rollout is set to start immediately, with launch dates targeted for the second half of the financial year, deployed on the Microsoft Azure cloud
  • Pro Medicus is down 1.1 per cent, trading at $54.01 at 12:20 pm AEST

Pro Medicus (PME)’s wholly owned subsidiary has signed a $40 million contract with Novant Health.

Visage Imaging penned the seven-year contract which will see the company’s Visage 7 Enterprise Imaging Platform and Visage 7 Workflow module implemented throughout Novant Health, providing a unified diagnostic imaging platform across the network.  

Planning ahead of the rollout is set to start immediately, with launch dates targeted for the second half of the financial year.

Pro Medicus CEO Sam Hupert explained the implementation would be fully deployed on the Microsoft Azure cloud.

“Novant Health is our seventh major North American contract in less than 18 months and our equal largest deal to date, underpinning the strong momentum we continue to build in the market,” Dr Hupert said.

Novant Health also joins an increasing number of clients to opt for a fully cloud-based solution.

“Our pipeline remains strong. Deals like this confirm our view that Visage 7, with its proven cloud native technology and modular design, provides us with a significant strategic advantage that enables us to address opportunities across a growing segment of the market both in North America and other regions,” Dr Hupert said.

Pro Medicus was down 1.1 per cent, trading at $54.01 at 12:20 pm AEST.

PME by the numbers
More From The Market Online

4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study

Respiratory imaging technology company, 4DMedical (ASX:4DX) has entered into a research agreement with the West Los…

Recce Pharma picks up Chinese patent for anti-infective drugs

Recce Pharmaceuticals (ASX:RCE) has confirmed its receipt of a patent in China to protect its class…

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…

Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA…